# Immune Modulation by Misoprostol

> **NCT02259309** · EARLY_PHASE1 · COMPLETED · sponsor: **Vanderbilt University** · enrollment: 15 (actual)

## Conditions studied

- Gynecological Infection

## Interventions

- **DRUG:** Misoprostol - buccal
- **DRUG:** Misoprostol - vaginal

## Key facts

- **NCT ID:** NCT02259309
- **Lead sponsor:** Vanderbilt University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2015-07
- **Final completion:** 2015-11
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2016-01-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02259309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02259309, "Immune Modulation by Misoprostol". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02259309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*